Acquiring Company
Norgine
Acquired Company
Theravia
ParisBiotechnologyBiotechnologyHealth CareMedicalPharmaceuticalDescription
Norgine has successfully completed the acquisition of Theravia, enhancing its portfolio in rare disease medicines. This strategic move will help Norgine deliver life-changing therapies to patients in high unmet medical needs. The integration process will align both companies' operations and expertise. Theravia will now operate as a wholly owned subsidiary of Norgine.
Quick answer
Norgine is acquiring Theravia, announced August 14, 2025.
- How much did Norgine pay for Theravia?
- The deal value was not disclosed.
- What does Norgine do?
- Norgine is a European specialty pharmaceutical company that has strived to deliver innovative medicines to patients for over a century.
- Where are Norgine and Theravia based?
- Theravia is based in Paris, Ile-de-France, France.
- Who are the decision-makers at Norgine?
- Fundz holds 1 contact at Norgine. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Pharmaceutical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Esteve Pharmaceuticals acquires Caprelsa® from Sanofi (July 1, 2025)
- Avanos Medical acquires Nexus Medical for growth (September 15, 2025)
- Edwards Lifesciences acquires Vectorious for $497M, $497M (September 4, 2025)
- Gryphon Digital Technologies merges with American Bitcoin (August 29, 2025)
- Teleflex finalizes acquisition of Biotronik's business (July 2, 2025)
- Pfizer to acquire Metsera for $7.3 billion, $7.3B (September 22, 2025)
Who to call at Norgine, and when
When Norgine changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Norgine raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Norgine, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Norgine. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Norgine makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Theravia?
Theravia was acquired by Norgine. The deal was reported on August 14, 2025. Norgine is a European specialty pharmaceutical company that has strived to deliver innovative medicines to patients for over a century. Norgine is privately held and operates in Biotechnology.
When did Norgine acquire Theravia?
Norgine's acquisition of Theravia was reported on August 14, 2025. Norgine has successfully completed the acquisition of Theravia, enhancing its portfolio in rare disease medicines. This strategic move will help Norgine deliver life-changing therapies to patients in high unmet medical needs. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Theravia do?
Theravia is an international pharmaceutical laboratory specializing in rare or neglected diseases. It is privately held, operating in Biotechnology, and is based in Paris.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.